Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
Oncobiologics, Inc. (OTLK) had Debt to Equity Ratio of -1.02 for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-46.36M |
|
-- |
|
-- |
|
$12.39M |
|
$-12.39M |
|
$-33.96M |
|
$-46.35M |
|
$-46.35M |
|
$-46.36M |
|
$-46.36M |
|
$-46.36M |
|
$-46.36M |
|
$-12.39M |
|
$-12.36M |
|
30.87M |
|
30.87M |
|
$-1.50 |
|
$-1.50 |
|
| Balance Sheet Financials | |
$17.81M |
|
-- |
|
$1.27M |
|
$19.08M |
|
$24.82M |
|
$21.05M |
|
$26.72M |
|
$51.54M |
|
$-32.46M |
|
$-32.46M |
|
$-32.46M |
|
32.91M |
|
| Cash Flow Statement Financials | |
$-27.55M |
|
-- |
|
$20.18M |
|
$14.93M |
|
$7.56M |
|
$-7.37M |
|
$5.40M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.72 |
|
-- |
|
-- |
|
-1.84 |
|
|
Debt to Equity Ratio |
-1.02 |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-27.55M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
142.80% |
|
142.80% |
|
-243.02% |
|
406.02% |
|
$-0.99 |
|
$-0.89 |
|
$-0.89 |
|